TiumBio Co., Ltd. (KOSDAQ:321550)

TiumBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 18, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	178,832	112,386	240,562	302,627	461,602	496,808
Market Cap Growth	67.37%	-53.28%	-20.51%	-34.44%	-7.09%	19.98%
Enterprise Value	181,824	130,114	261,518	295,725	419,268	447,505
Last Close Price	6150.00	4315.00	9770.00	12600.00	19300.00	21100.00
PS Ratio	19.18	16.55	49.11	33.19	8127.16	473.63
PB Ratio	3.68	1.79	2.96	4.86	5.11	6.02
P/TBV Ratio	5.04	2.28	3.54	5.10	5.40	6.15
EV/Sales Ratio	19.50	19.16	53.38	32.44	7381.81	426.62
Debt / Equity Ratio	0.76	0.48	0.36	0.37	0.22	0.02
Net Debt / Equity Ratio	-0.17	-0.33	-0.14	-0.19	-0.23	-0.82
Net Debt / EBITDA Ratio	0.56	1.37	0.47	0.54	0.69	5.48
Net Debt / FCF Ratio	0.59	1.23	0.29	0.44	0.58	6.57
Asset Turnover	0.09	0.06	0.05	0.09	0.00	0.01
Quick Ratio	1.64	1.89	3.19	1.18	9.31	39.00
Current Ratio	1.95	2.15	3.48	1.34	9.38	39.32
Return on Equity (ROE)	-25.94%	-32.75%	-26.54%	-41.16%	-37.32%	-13.85%
Return on Assets (ROA)	-11.73%	-10.30%	-16.12%	-15.05%	-20.22%	-9.30%
Return on Capital Employed (ROCE)	-24.80%	-23.40%	-26.10%	-38.80%	-29.10%	-15.90%
Earnings Yield	-6.56%	-18.37%	-7.45%	-9.86%	-6.85%	-2.44%
FCF Yield	-7.95%	-14.83%	-16.19%	-8.99%	-7.94%	-2.06%
Buyback Yield / Dilution	-4.33%	-5.91%	-1.79%	-0.63%	-1.39%	-17.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.